Vertex names Jonathan Poole finance chief as Crinetics buy closes

Vertex Pharmaceuticals has named Jonathan Poole as its new finance chief, coinciding with the closing of Crinetics Pharmaceuticals' acquisition. The executive appointment aligns with broader corporate restructuring efforts.